LeonaBio (LONA) Shares Outstanding (Diluted Average) (2021 - 2026)

LeonaBio (LONA) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $19.0 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 387.34% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 387.34% YoY) and the FY2025 annual result came in at $4.3 million, up 11.12% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $19.0 million in Q1 2026 per LONA's latest filing, from $4.3 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $39.1 million in Q2 2025 and bottomed at $3.8 million in Q4 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $37.7 million (2022), against an average of $26.9 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) tumbled 89.88%; it then soared 387.34% in 2026.
• Tracing LONA's Shares Outstanding (Diluted Average) over 5 years: stood at $37.7 million in 2022, then grew by 0.76% to $38.0 million in 2023, then plunged by 89.88% to $3.8 million in 2024, then gained by 11.12% to $4.3 million in 2025, then surged by 345.0% to $19.0 million in 2026.
• Per Business Quant, the three latest LONA Shares Outstanding (Diluted Average) figures stand at $19.0 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025).

Peer Comparison